Orthofix Medical Past Earnings Performance

Past criteria checks 0/6

Orthofix Medical's earnings have been declining at an average annual rate of -60.7%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 7.6% per year.

Key information

-60.7%

Earnings growth rate

-50.6%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate7.6%
Return on equity-25.3%
Net Margin-20.3%
Next Earnings Update07 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Orthofix Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:OM2 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23747-15150377
30 Sep 23668-13645772
30 Jun 23598-11841366
31 Mar 23529-7635960
31 Dec 22461-2030949
30 Sep 22464-4529949
30 Jun 22462-3729750
31 Mar 22465-3729750
31 Dec 21464-3829150
30 Sep 21457-1528847
30 Jun 21456-828544
31 Mar 21407-2926740
31 Dec 20407327239
30 Sep 204102427737
30 Jun 20413-2228435
31 Mar 20456-430435
31 Dec 19460-2830935
30 Sep 19460-3130235
30 Jun 19458829837
31 Mar 19453929136
31 Dec 184531428933
30 Sep 18449628433
30 Jun 184421127830
31 Mar 184401527729
31 Dec 17434727630
30 Sep 17425127429
30 Jun 17419827229
31 Mar 17414-326629
31 Dec 16410326129
30 Sep 164061125429
30 Jun 16409025629
31 Mar 164051025928
31 Dec 15396-227426
30 Sep 15392-1027425
30 Jun 15392-927125
31 Mar 15392-1026625
31 Dec 14402-426125
30 Sep 14408-826725
30 Jun 14399-2525925
31 Mar 14395-2625627
31 Dec 13398-1825627
30 Sep 13402823126
30 Jun 134183523327

Quality Earnings: OM2 is currently unprofitable.

Growing Profit Margin: OM2 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OM2 is unprofitable, and losses have increased over the past 5 years at a rate of 60.7% per year.

Accelerating Growth: Unable to compare OM2's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OM2 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: OM2 has a negative Return on Equity (-25.29%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.